234 related articles for article (PubMed ID: 35327648)
21. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
Shames I; Fraser A; Colby J; Orfali W; Snipes GJ
J Neuropathol Exp Neurol; 2003 Jul; 62(7):751-64. PubMed ID: 12901701
[TBL] [Abstract][Full Text] [Related]
22. Expression pattern of the peripheral myelin protein 22kDa (PMP22) in neural and non-neural tissue types of adult wildtype and Trembler mice--a comparative study.
Rautenstrauss B; Zechner U; Hameister H; Grehl H; Liehr T
J Peripher Nerv Syst; 1998; 3(2):117-24. PubMed ID: 10959245
[TBL] [Abstract][Full Text] [Related]
23. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene.
Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM
Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112
[TBL] [Abstract][Full Text] [Related]
24. Exposure at the cell surface is required for gas3/PMP22 To regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases.
Brancolini C; Edomi P; Marzinotto S; Schneider C
Mol Biol Cell; 2000 Sep; 11(9):2901-14. PubMed ID: 10982389
[TBL] [Abstract][Full Text] [Related]
25. Pmp22 super-enhancer deletion causes tomacula formation and conduction block in peripheral nerves.
Pantera H; Hu B; Moiseev D; Dunham C; Rashid J; Moran JJ; Krentz K; Rubinstein CD; Won S; Li J; Svaren J
Hum Mol Genet; 2020 Jun; 29(10):1689-1699. PubMed ID: 32356557
[TBL] [Abstract][Full Text] [Related]
26. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
Sancho S; Young P; Suter U
Brain; 2001 Nov; 124(Pt 11):2177-87. PubMed ID: 11673320
[TBL] [Abstract][Full Text] [Related]
27. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
28. Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
Lopez-Anido C; Poitelon Y; Gopinath C; Moran JJ; Ma KH; Law WD; Antonellis A; Feltri ML; Svaren J
Hum Mol Genet; 2016 Jul; 25(14):3055-3069. PubMed ID: 27288457
[TBL] [Abstract][Full Text] [Related]
29. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
30. Structural basis for the Trembler-J phenotype of Charcot-Marie-Tooth disease.
Sakakura M; Hadziselimovic A; Wang Z; Schey KL; Sanders CR
Structure; 2011 Aug; 19(8):1160-9. PubMed ID: 21827951
[TBL] [Abstract][Full Text] [Related]
31. Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A.
Robertson AM; Perea J; McGuigan A; King RH; Muddle JR; Gabreëls-Festen AA; Thomas PK; Huxley C
J Anat; 2002 Apr; 200(4):377-90. PubMed ID: 12090404
[TBL] [Abstract][Full Text] [Related]
32. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
[TBL] [Abstract][Full Text] [Related]
33. Abnormal Schwann cell/axon interactions in the Trembler-J mouse.
Robertson AM; King RH; Muddle JR; Thomas PK
J Anat; 1997 Apr; 190 ( Pt 3)(Pt 3):423-32. PubMed ID: 9147228
[TBL] [Abstract][Full Text] [Related]
34. Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina.
Amici SA; Dunn WA; Murphy AJ; Adams NC; Gale NW; Valenzuela DM; Yancopoulos GD; Notterpek L
J Neurosci; 2006 Jan; 26(4):1179-89. PubMed ID: 16436605
[TBL] [Abstract][Full Text] [Related]
35. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A.
Perea J; Robertson A; Tolmachova T; Muddle J; King RH; Ponsford S; Thomas PK; Huxley C
Hum Mol Genet; 2001 May; 10(10):1007-18. PubMed ID: 11331611
[TBL] [Abstract][Full Text] [Related]
36. Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells.
Pareek S; Suter U; Snipes GJ; Welcher AA; Shooter EM; Murphy RA
J Biol Chem; 1993 May; 268(14):10372-9. PubMed ID: 8486695
[TBL] [Abstract][Full Text] [Related]
37. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies.
Naef R; Suter U
Neurobiol Dis; 1999 Feb; 6(1):1-14. PubMed ID: 10078969
[TBL] [Abstract][Full Text] [Related]
38. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
39. The peripheral myelin protein 22 and epithelial membrane protein family.
Jetten AM; Suter U
Prog Nucleic Acid Res Mol Biol; 2000; 64():97-129. PubMed ID: 10697408
[TBL] [Abstract][Full Text] [Related]
40. Rapamycin improves peripheral nerve myelination while it fails to benefit neuromuscular performance in neuropathic mice.
Nicks J; Lee S; Harris A; Falk DJ; Todd AG; Arredondo K; Dunn WA; Notterpek L
Neurobiol Dis; 2014 Oct; 70():224-36. PubMed ID: 25014022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
